These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18346015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
    Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE.
    Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prevalence of and risk factors for hepatitis C in blood donors].
    Ladrón-de Guevara L, Gómez N, Vázquez-Cantarell M, García-Méndez S, Di Silvio M.
    Rev Gastroenterol Mex; 2002 Oct; 67(1):11-6. PubMed ID: 12066425
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M.
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
    Imarengiaye CO, Enosolease ME, Iribhogbe PE, Ehigiegba AE.
    Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O, Ejele OA, Nwauche CA.
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [Abstract] [Full Text] [Related]

  • 17. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP.
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [Abstract] [Full Text] [Related]

  • 18. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study.
    Tanwandee T, Piratvisuth T, Phornphutkul K, Mairiang P, Permpikul P, Poovorawan Y.
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S79-83. PubMed ID: 17722300
    [Abstract] [Full Text] [Related]

  • 19. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.